IL1B and juvenile idiopathic arthritis: The immune cells and the inflammatory mediators interleukin (IL)-1, IL-6, and IL-17, and the tumor necrosis factor (TNF)-α are well-studied cytokines that actively contribute to the clinical phenotypes of JIA, such as synovial inflammation and bone resorption [3,4].